Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Health - Purple Foxy Ladies originally published at Health - Purple Foxy Ladies
Presentation to include clinical data from a phase 2 study of Gruticibart (AB023), a factor XI-targeted antibody being developed for the treatment and prevention of thrombosis and inflammation
PORTLAND, Ore. - December 6, 2022 - (Newswire.com)
Aronora Inc., a clinical-stage biotechnology company developing next-generation therapeutics for blood clotting diseases, announced today that clinical data from a phase 2 study of Gruticibart will be presented at the 64th American Society of Hematology (ASH) Annual Meeting, taking place in New Orleans, Dec. 10-13, 2022.
Gruticibart (AB023) is a unique recombinant antibody that targets coagulation factor XI (FXI) and specifically inhibits FXI activation by factor XII without blocking its activation by thrombin. It has been specifically designed to treat and prevent blood clots without causing an increased bleeding risk. This phase 2 study evaluated the safety and efficacy of Gruticibart for the prevention of catheter-associated thrombosis in patients with cancer receiving chemotherapy. Additional information about the trial can be found at https://clinicaltrials.gov/ct2/show/NCT04465760.
Details of the oral presentation are as follows:
Title: Factor XI Inhibition for the Prevention of Catheter-Associated Thrombosis in Cancer Patients Undergoing Central Line Placement: A Phase 2 Clinical Trial
Publication Number: 518
Session: 332. Thrombosis and Anticoagulation: Clinical and Epidemiological: Cancer-associated Thrombosis: Risk Stratification, Prevention, and Treatment
Session Date: Sunday, Dec. 11, 2022
Session Time: 12-1:30 p.m.
Presentation Time: 12:15 p.m.
Abstracts are available via the ASH meeting website at https://www.hematology.org/meetings/annual-meeting/abstracts.
Preclinical and early clinical development has been partially supported by the National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) under award numbers R44HL106919, R44HL128016, and R44AI088937. This content is solely the responsibility of Aronora and does not necessarily represent the official views of the NIH.
For more information, please visit www.aronorabio.com.
Contact Information:
Erik Tucker
President & CEO
[email protected]
(503) 530-6842
Press Release Service by Newswire.com
Original Source: Aronora Announces Clinical Data to Be Presented at the 64th American Society of Hematology Annual Meeting
Health - Purple Foxy Ladies originally published at Health - Purple Foxy Ladies
More Stories
North Shore Pediatric Therapy Expands Locations & Offers Rapid Early Autism Testing Amidst National Waitlists
Autism testing for kids 4 and under in Arlington Heights, Deerfield, and Naperville fills a much-needed gap for local families.
North Shore Pediatr…
DocVA Launches Cutting-Edge Virtual Medical Assistant Services, Revolutionizing Healthcare Operations
Boost Efficiency and Elevate Patient Care With DocVA’s New Virtual Assistant Services
FORT LAUDERDALE, Fla., July 18, 2024 (Newswire.com)
–
DocVA, a leader in the virtual medical assistant staffing industry with years of experience, announces the launch of its comprehensive suite of remote healthcare support services. This innovative offering aims to transform medical practices by providing highly skilled virtual assistants capable of handling various administrative and clinical support tasks.
Virtual Medical Assistant Provider Offers Tailored Solutions to Enhance Patient Care and Streamline Practice Operations
“The world of healthcare is constantly changing, and at DocVA, we’re committed to staying ahead of the curve,” said Nathaniel Barz, CEO of DocVA, who has a decade of experience delivering excellent customer service in the staffing industry. “Our mission is to help as many healthcare practices as possible in the U.S., Canada, and eventually the world by addressing the critical issues that arose post-COVID, such as staff burnout and shortages.”
Comprehensive Virtual Medical Assistant Services
DocVA’s range of services includes:
- Virtual Medical Receptionist: Handling phone calls, scheduling appointments, managing prescription refill requests, and verifying insurance eligibility
- Virtual Medical Billing and Insurance Assistant: Managing payments, insurance verification, claims submissions, and pre-authorizations
- Virtual Medical Assistant: Updating medical records, coordinating with other providers, and fielding patient questions
- Virtual Medical Scribe: Providing real-time documentation during patient exams, ensuring EMRs stay current
Benefits for All Stakeholders
By partnering with DocVA, healthcare providers can expect:
- Improved office efficiency and smoother daily operations
- Enhanced patient satisfaction through elite-level customer service
- Significant cost savings compared to hiring in-house staff
- HIPAA-compliant services that ensure patient privacy and data security
- Flexibility to scale support based on practice needs
- Reduced staff burnout and improved work-life balance
- Increased profitability for practices
“Our virtual assistants create a win-win-win situation,” Nathan added. “Staff love it, doctors love it, and patients love it. We’re not just improving healthcare operations but also providing opportunities for people in developing countries to achieve an upper-middle-class lifestyle.”
About DocVA
DocVA is a seasoned virtual medical assistant staffing leader, with two years of specialized experience in the healthcare industry. Our team has placed thousands of virtual medical assistants in different practices across the U.S. Building on lessons learned from previous ventures, DocVA is dedicated to constant improvement and innovation. By leveraging cutting-edge AI technology and a team of highly skilled professionals, DocVA enables medical practices to streamline operations, improve patient care, and reduce operational costs.
Discover more about how DocVA is revolutionizing healthcare support at https://docva.com or contact:
Contact Information:
Nathaniel Barz
Founder & CEO
DocVA
[email protected]
+1 (954) 304-9702
110 E. Broward Blvd., Suite 1700, Fort Lauderdale, Florida 33312, United States
Contact Information:
Nathaniel Barz
CEO
+1 (954) 304-9702
Original Source:
DocVA Launches Cutting-Edge Virtual Medical Assistant Services, Revolutionizing Healthcare Operations
Protenus Granted Seventh Patent for Drug Diversion Surveillance Technology
New patent granted assists hospitals with greater coverage to support drug waste events
Protenus Protenus logo
BA…
HydroCorp Redefines Piping Schematics at Leading Clinic Hospital Network
Enhancing water and medical gas system management and emergency preparedness through comprehensive visual surveying documentation
Piping hazard ide…
PRISM Vision Group at ASRS Annual Meeting — Stockholm, Sweden
PRISM Vision Group-affiliated physicians are well represented at the ASRS Annual Meeting.
NEW PROVIDENCE, N.J., July 17, …
LEARNROLL LLC Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation
American Heart Association consortium advances development of evidence-based health tech solutions
Learnroll Logo
…